The specific answers to those questions are forthcoming, as the 60-year-old Philadelphia-based pharmacy chain begins its second bankruptcy process in two years
One KFF analysis estimates that roughly 36 million non-elderly Americans with employer coverage alone meet BMI criteria for a GLP-1, while only a small fraction are taking one today, which points to large latent demand constrained by cost
The glucagon receptor activation in retatrutide adds another layer of concern
Specifically, falling asleep fine but waking at 24 AM and struggling to get back to sleep
For GLP-1 medications specifically, this faster absorption can translate to a slightly quicker onset of appetite suppression after each dose, which is directly relevant when your goal is fat loss
The best time to build routines is during treatment, when cravings are lower and appetite feels more manageable